NanoPhylax is a biotechnology company based in Lincoln, Nebraska, specializing in the development of innovative nanoparticle therapeutics. Founded in 2023, we are dedicated to addressing neurological disorders, particularly traumatic brain injury, by leveraging our proprietary technology to deliver antioxidant nanoparticles across the blood-brain barrier.

Our core focus is on creating a ‘NanoGuardian’ for the brain, utilizing antioxidant nanoparticles designed to scavenge free radicals and mitigate oxidative stress. We’re committed to advancing therapies that offer a significant improvement over existing treatments.

NanoPhylax’s technology, centered around NP001™ and NP003™, represents a crucial step forward in neurological medicine. We are actively seeking collaborators and expanding our team to accelerate the development and commercialization of these groundbreaking solutions.

We operate from the Nebraska Innovation Campus, and our team comprises experienced scientists and researchers passionate about translating cutting-edge research into tangible benefits for patients.

NP001™ | NanoPhylax

Product description

NanoPhylax Lincoln, United States (US)

Price: N/A

NanoPhylax
Lincoln, United States (US)